Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Probiotic484 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19660 | 26430826 | J Am Coll Nutr | Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial. | 2015 | Details |
| A19719 | 26395746 | Int J Obes (Lond) | A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. | 2015 | Details |
| A19750 | 26378643 | Semin Liver Dis | The Gut Microbiota and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19758 | 26375281 | PLoS One | Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver. | 2015 | Details |
| A19808 | 26338727 | Gut | The gut microbiota and host health: a new clinical frontier. | 2015 | Details |
| A19831 | 26318867 | Transl Res | Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. | 2015 | Details |
| A19878 | 26289505 | Niger J Clin Pract | Nonalcoholic fatty liver disease: Synopsis of current developments. | 2016 | Details |
| A20106 | 26151226 | Clin Biochem | Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. | 2015 | Details |
| A20118 | 26143342 | Dig Dis Sci | Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20222 | 26078557 | World J Gastroenterol | What are the effects of proton pump inhibitors on the small intestine? | 2015 | Details |
| A20272 | 26052375 | World J Hepatol | Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets. | 2015 | Details |
| A20382 | 26000656 | Future Microbiol | Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. | 2015 | Details |
| A20563 | 25882223 | Curr Drug Targets | Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20621 | 25848479 | World J Hepatol | Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. | 2015 | Details |
| A20675 | 25809828 | Int J Obes (Lond) | Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. | 2015 | Details |
| A20854 | 25684933 | World J Gastroenterol | Gut microbiota and liver diseases. | 2015 | Details |
| A21079 | 25548472 | World J Gastroenterol | Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. | 2014 | Details |
| A21167 | 25506780 | JAMA Pediatr | Nonalcoholic fatty liver disease: a challenge for pediatricians. | 2015 | Details |
| A21217 | 25473159 | World J Gastroenterol | Gut microbiota and metabolic syndrome. | 2014 | Details |
| A21226 | 25469019 | World J Gastroenterol | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. | 2014 | Details |
| A21229 | 25469013 | World J Gastroenterol | Obesity, fatty liver disease and intestinal microbiota. | 2014 | Details |
| A21240 | 25460293 | Horm Mol Biol Clin Investig | Nutrition: a promising route for prevention and management of obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A21333 | 25400436 | World J Gastroenterol | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. | 2014 | Details |
| A21388 | 25353664 | Nutrients | Non-alcoholic fatty liver disease in children: focus on nutritional interventions. | 2014 | Details |
| A21438 | 25317840 | Food Funct | Lactobacillus plantarum NCU116 improves liver function, oxidative stress and lipid metabolism in rats with high fat diet induced non-alcoholic fatty liver disease. | 2014 | Details |
| A21449 | 25310763 | Pediatr Res | Gut microbiome and nonalcoholic fatty liver diseases. | 2014 | Details |
| A21459 | 25306266 | J Dairy Sci | Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. | 2014 | Details |
| A21508 | 25267322 | Aliment Pharmacol Ther | Review article: the management of paediatric nonalcoholic fatty liver disease. | 2014 | Details |
| A21563 | 25225347 | Adv Nutr | Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. | 2014 | Details |
| A21651 | 25152979 | Ann Hepatol | Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients. | 2015 | Details |
| A21811 | 25030027 | BMC Complement Altern Med | Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity. | 2014 | Details |
| A21912 | 24966608 | World J Gastroenterol | Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. | 2014 | Details |
| A22088 | 24829682 | Middle East J Dig Dis | Probiotics and Nonalcoholic Fatty liver Disease. | 2013 | Details |
| A22114 | 24811405 | Appl Microbiol Biotechnol | Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. | 2014 | Details |
| A22228 | 24738701 | Aliment Pharmacol Ther | Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. | 2014 | Details |
| A22409 | 24605611 | Lik Sprava | [Effect of probiotics on proinflammatory cytokines level in patients with type 2 diabetes and nonalcoholic fatty liver disease]. | 2013 | Details |
| A22413 | 24604038 | Indian J Med Res | Probiotic foods: can their increasing use in India ameliorate the burden of chronic lifestyle disorders? | 2014 | Details |
| A22426 | 24587653 | World J Gastroenterol | Dietary habits and behaviors associated with nonalcoholic fatty liver disease. | 2014 | Details |
| A22519 | 24495527 | Proc Nutr Soc | 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk. | 2014 | Details |
| A22546 | 24475018 | PLoS One | Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. | 2014 | Details |
| A22627 | 24400795 | Immunology | Probiotic antigens stimulate hepatic natural killer T cells. | 2014 | Details |
| A22679 | 26417275 | EXCLI J | Non-alcoholic fatty liver disease, diet and gut microbiota. | 2014 | Details |
| A22743 | 24337650 | Semin Immunopathol | Microbiota and nonalcoholic steatohepatitis. | 2013 | Details |
| A22847 | 24274865 | Clin Liver Dis | Obesity and NAFLD: the role of bacteria and microbiota. | 2013 | Details |
| A22853 | 24251710 | J Gastroenterol Hepatol | Role of diet and nutritional management in non-alcoholic fatty liver disease. | 2013 | Details |
| A22925 | 24206433 | Aliment Pharmacol Ther | Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. | 2013 | Details |
| A22932 | 24196453 | Semin Immunopathol | Gut microbiome and metabolic diseases. | 2013 | Details |
| A22946 | 24187469 | World J Gastroenterol | Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. | 2013 | Details |
| A22966 | 24166662 | Dig Dis Sci | Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats. | 2013 | Details |
| A23208 | 23958600 | Nat Rev Gastroenterol Hepatol | The Gordian Knot of dysbiosis, obesity and NAFLD. | 2013 | Details |
| A23241 | 23930163 | Int J Prev Med | Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial. | 2013 | Details |
| A23300 | 23885277 | Hepat Mon | Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences. | 2013 | Details |
| A23313 | 23855299 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. | 2013 | Details |
| A23324 | 23870449 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: more on novel treatment targets. | 2013 | Details |
| A23542 | 23696823 | PLoS One | Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. | 2013 | Details |
| A23625 | 23619251 | Ann Hepatol | Probiotics in non-alcoholic fatty liver disease: which and when. | 2013 | Details |
| A23702 | 23554890 | PLoS One | Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters. | 2013 | Details |
| A23719 | 23538296 | JPEN J Parenter Enteral Nutr | Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? | 2013 | Details |
| A23899 | 23396737 | Ann Hepatol | Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. | 2013 | Details |
| A24131 | 23197979 | Gastroenterol Res Pract | Nutrition therapy for liver diseases based on the status of nutritional intake. | 2012 | Details |
| A24251 | 23075296 | Ital J Pediatr | Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. | 2012 | Details |
| A24600 | 22706738 | Turk J Gastroenterol | Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats. | 2012 | Details |
| A24605 | 22700625 | Ann Hepatol |  Gut microbiota and nonalcoholic fatty liver disease. | 2012 | Details |
| A24639 | 22661622 | J Am Coll Nutr | Probiotics in the treatment of the liver diseases. | 2012 | Details |
| A24834 | 22447263 | Semin Respir Crit Care Med | Infectious complications of acute and chronic liver disease. | 2012 | Details |
| A25013 | 22247604 | J Clin Biochem Nutr | Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. | 2011 | Details |
| A25279 | 22013734 | Eur Rev Med Pharmacol Sci | Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. | 2011 | Details |
| A25670 | 21563361 | Eksp Klin Gastroenterol | [Advisability of using probiotics in the treatment of atherogenic dyslipidemia]. | 2011 | Details |
| A25939 | 21292470 | J Nutr Biochem | Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. | 2011 | Details |
| A26038 | 21180596 | Therap Adv Gastroenterol | Treatment options for nonalcoholic fatty liver disease. | 2010 | Details |
| A26152 | 21033080 | Eksp Klin Gastroenterol | [Hypolipidemic therapy in patients with non-alcoholic fatty liver disease]. | 2010 | Details |
| A26251 | 20838401 | Int J Obes (Lond) | Nonalcoholic fatty liver disease: a challenge for pediatricians. | 2010 | Details |
| A26272 | 20804522 | Obes Rev | Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? | 2010 | Details |
| A26711 | 19915460 | Curr Opin Lipidol | Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. | 2010 | Details |
| A27010 | 19359436 | Gut | Toll-like receptors as targets in chronic liver diseases. | 2009 | Details |
| A27027 | 19321579 | J Nutr | Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. | 2009 | Details |
| A27137 | 19115316 | Hepatology | VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. | 2009 | Details |
| A27364 | 18537660 | Curr Pharm Des | Genomics can advance the potential for probiotic cultures to improve liver and overall health. | 2008 | Details |
| A27851 | 17253543 | Cochrane Database Syst Rev | Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. | 2007 | Details |
| A27893 | 17073635 | Curr Med Chem | Current pharmacological treatment of nonalcoholic fatty liver. | 2006 | Details |
| A28256 | 15942443 | J Clin Gastroenterol | Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. | 2005 | Details |
| A28494 | 12540784 | Hepatology | Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. | 2003 | Details |
| A28638 | 35211093 | Front Endocrinol (Lausanne) | The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis. | 2022 | Details |
| A29173 | 34473374 | FASEB J | Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases. | 2021 | Details |
| A30489 | 32355675 | Hepatobiliary Surg Nutr | Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model. | 2020 | Details |
| A31416 | 30618372 | Ugeskr Laeger | [The gut microbiome is important in chronic liver disease]. | 2019 | Details |
| A31619 | 30186272 | Front Microbiol | Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels. | 2018 | Details |
| A31622 | 31719890 | Cell Mol Bioeng | Engineered Stochastic Adhesion Between Microbes as a Protection Mechanism Against Environmental Stress. | 2018 | Details |
| A31765 | 29900399 | Data Brief | The effect of synbiotics Bifidobacterium infantis and milk oligosaccharides on shaping gut microbiota community structure and NASH treatment. | 2018 | Details |
| A32721 | 29922669 | Inflamm Intest Dis | Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? | 2016 | Details |
| A34367 | 23638162 | PLoS One | Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study. | 2013 | Details |
| A34631 | 23029000 | PLoS One | VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. | 2012 | Details |
| A37611 | 15277442 | Diabetes Care | Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. | 2004 | Details |
| A37639 | 15220676 | J Clin Gastroenterol | Probiotics: a potential target for the prevention and treatment of steatohepatitis. | 2004 | Details |
| A42396 | 34674606 | Gut Microbes | Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases? | 2022 | Details |
| A42412 | 34603218 | Front Endocrinol (Lausanne) | Editorial: The Brain - Gut - Microbiome Network in Metabolic Regulation and Dysregulation. | 2021 | Details |
| A42511 | 34328191 | Int J Mol Med | Dysbiosis and liver diseases (Review). | 2021 | Details |
| A42843 | 33317240 | Clin Mol Hepatol | Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try. | 2020 | Details |
| A42909 | 33140925 | Minerva Med | Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease. | 2020 | Details |
| A42980 | 32895142 | Nan Fang Yi Ke Da Xue Xue Bao | [Gut microbiota-an important contributor to liver diseases]. | 2020 | Details |